Thu 11/17/2022 07:33 AM
Global oncology services provider GenesisCare has received approaches from ‘high quality’ prospective investors offering to provide fresh capital, management told lenders on a call earlier this month. It provided no details on what form any new money would take.
Given the group’s 40x plus net leverage, lenders are concerned that the company could resort to an Envision
-style deal and shift its best assets - the Australian and European segments - out of the restricted group to provide security...
This article is an example of the content you may receive if you subscribe to a product of Reorg Research, Inc. or one of its affiliates (collectively, “Reorg”). The information contained herein should not be construed as legal, investment, accounting or other professional services advice on any subject. Reorg, its affiliates, officers, directors, partners and employees expressly disclaim all liability in respect to actions taken or not taken based on any or all the contents of this publication. Copyright © 2024 Reorg Research, Inc. All rights reserved.